Characterization of CD40 Signaling Determinants Regulating Nuclear Factor-κB Activation in B Lymphocytes

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4898-4906

  Hsing, Yina ^a   Hostager, Bruce S ^a   Bishop, Gail A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; EPITOPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; RELB PROTEIN, HUMAN; RELB PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CULTURE; CHEMISTRY; CYTOPLASM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT; CYTOPLASM; EPITOPES, B-LYMPHOCYTE; HUMANS; LYMPHOMA, B-CELL; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031573208     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403.
2. Armitage, R. J. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6:407.
3. Baker, S. J., and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1.
4. Beutler, B., and C. van Huftel. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667.
5. Hodgkin, P. D., L. C. Yamashita, R. L. Coffman, and M. R. Kehry. 1990. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J. Immunol. 145:2025.
6. Aversa, G., J. Punnonen, J. M. Carballido, B. G. Cocks, and J. F. de Vries. 1994. CD40 ligand-CD40 interaction in Ig isotype switching in mature und immature human B cells. Semin. Immunol. 6:295.
7. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
8. Björck, P., and S. Paulie. 1993. Inhibition of LFA-1-dependent human B-cell aggregation induced by CD40 antibodies and interleukin-4 leads to decreased IgE synthesis. Immunology 78:218.
9. Barrett, T. B., G. Shu, and E. A Clark. 1991. CD40 signaling activates CD11a/ CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722.
10. Garrone, P., E. M. Neidhardt, F. Garcia, L. Galibert, C. van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265.
11. Schattner, E. J., K. B. Elkon, D. H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
12. Lalmanach-Girard, A. C., T. C. Chiles, D. C. Parker, and T. L. Rothstein. 1993. T cell-dependent induction of NF-κB in B cells. J. Exp. Med. 177:1215.
13. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly actuates NF-κB. J. Immunol. 153:4357.
14. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
15. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
16. Ganchi, P. A., S. C. Sun, W. C. Green, and D. W. Ballard. 1992. IκB/Mad-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3:1339.
17. Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53: 211.
18. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485.
19. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of IκB alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259.
20. DiDonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15:1302.
21. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB. Nature 365:182.
22. Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1401.
23. Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel. 1995. N- and C-terminal sequences control degradation of MAD3/IκBκ in response to inducers of NF-κB. Mol. Cell. Biol. 15:5339.
24. Hanissian, S. H., and R. S. Geha. 1997. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379.
25. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, T. Yamamoto, and J. Inoue. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745.
26. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494.
27. Hu, H. M., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069.
28. Ishida, T., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J. Inoue. 1996. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93:9437.
29. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16:7098.
30. Cheng, G., and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-κB activation. Genes Dev. 10:963.
31. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540.
32. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
33. Nakano, H., H. Oshima, W. Chung, L. Williams-Abbott, C. F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:14661.
34. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443.
35. Hostager, B. S., Y. Hsing, D. E. Harms, and G. A. Bishop. 1996. Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 157:1047.
36. Imbert, V., R. A. Rupec, A. Livolsi, H. L. Pahl, E. B. Traenckner, C. Mueller-Dieckmann, D. Farahitar, B. Rossi, P. Auberger, P. A. Baeuerle, and J. Peyron. 1996. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα. Cell 86:787.
37. + B cells by clonal T cells and antigen. Proc. Natl. Aca. Sci. USA 83:7410.
38. Hamano, T., K. J. Kim, W. M. Leiserson, and R. Asofsky. 1982. Establishment of B cell lymphomas with B cell surface antigens. J. Immunol. 129:1403.
39. Paulie, S., A. Rosen, B. Ehlin-Henriksson, S. Braesch-Andersen, E. Jakobson, H. Koho, and P. Perlmann. 1989. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J. Immunol. 142:590.
40. Inui, S., T. Kaisho, H. Kikutani, I. Stamenkovic, B. Seed, E. A. Clark, and T. Kishimoto. 1990. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 20:1747.
41. Long, E. O., S. Rosen-Bronson, D. R. Karp, M. Malnati, R. P. Sekaly, and D. Jaraquemada. 1991. Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. Hum. Immunol. 31:229.
42. Van den Hoff, M. J., A. F. Moorman, and W. H. Lamers. 1992. Electroporation in "intracellular" buffer increases cell survival. Nucleic Acids Res. 20:2902.
43. Musci, M. A., L. R. Hendricks-Taylor, D. G. Motto, M. Paskind, J. Kamens, C. W. Turck, and G. A. Koretzky. 1997. Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J. Biol. Chem. 272:11674.
44. Harlow, E., and D. Lane. 1988. Antibodies, a Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, p. 298.
45. Dyer, R. B., and N. K. Herzog. 1995. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. Biotechniques 19:192.
46. Motto, D. G., S. E. Ross, J. Wu, L. R. Hendrick-Taylor, and G. A. Koretzky. 1996. Implications of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin-2 production. J. Exp. Med. 183:1937.
47. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769.
48. Francis, D. A., J. G. Karras, X. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151.
49. Miyamoto, S., P. J. Chiao, and I. M. Verma. 1994. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature B-cell lines. Mol. Cell. Biol. 14:3276.
50. Morio, T., S. Hanissian, and R. S. Geha. 1995. Characterization of a 23-kDa protein associated with CD40. Proc. Natl. Acad. Sci. USA 92:11633.
51. Harton, J. A., A. E. Van Hagen, and G. A. Bishop. 1995. The cytoplasmic and transmembrane domains of MHC class II β chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity 3:349.
52. Sanchez, M., Z. Misulovin, A. L. Burkhardt, S. Mahajan, T. Costa, R. Franke, J. B. Bolen, and M. Nussenzweig. 1993. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J. Exp. Med. 178:1049.
53. Perkins, N. D., R. M. Schmid, C. S. Duckett, K. Leung, N. R. Rice, and G. J. Nabel. 1992. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA 89:1529.
54. La Rosa, F. A., J. W. Pierce, and G. E. Sonenshein. 1994. Differential regulation of the c-myc oncogene promoter by the NF-κB Rel family of transcription factors. Mol. Cell. Biol. 14:1039.
55. Miyamoto, S., M. J. Schmittt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of κB-binding complexes during B-cell differentiation. Proc. Natl. Acad. Sci. USA 91:5056.
56. Pazin, M. J., P. L. Sheridan, K. Cannon, Z. Cao, J. G. Keck, J. T. Kadonaga, and K. A. Jones. 1996. NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37.
57. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1994. Activation of the B-cell surface receptor CD40 induces A20, a novel Zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343.
58. Ito, C. Y., A. G. Kazantsev, and A. S. Baldwin, Jr. 1994. Three NF-κB sites in the IκBα promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res. 22:3787.
59. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Green. 1993. NF-kappa B controls expression of inhibitor 1 kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259:1912.